Managing diabetes with continuous glucose monitors and remote monitoring for underserved populations
Establishing a Sustainable Diabetes Care Management Program Using Continuous Glucose Monitors and Remote Patient Monitoring for Underserved Populations in Safety Net Clinics
This study is testing if using continuous glucose monitors and remote support can help people with uncontrolled type 2 diabetes in underserved communities manage their blood sugar better and feel less stressed about their condition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Diabetes Solutions International Academic / other |
| Locations | 1 site (Greenfield, Massachusetts) |
| Trial ID | NCT06939413 on ClinicalTrials.gov |
What this trial studies
This 52-week prospective study aims to evaluate the effectiveness of a Diabetes Care Management Program that utilizes continuous glucose monitors (CGM) and remote patient monitoring (RPM) to improve glucose levels and reduce diabetes-related distress in individuals with uncontrolled type 2 diabetes. Participants will wear a CGM to track their glucose readings, which will be monitored remotely by a diabetes care team. The study will assess whether this approach leads to improved A1c levels and increased time spent within target glucose ranges. The program is designed to address the unique challenges faced by patients in underserved communities.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with type 2 diabetes and an A1c level greater than 8%.
Not a fit: Patients who are pregnant, have type 1 diabetes, or have certain serious health conditions such as active cancer treatment or end-stage renal disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and quality of life for patients with uncontrolled type 2 diabetes.
How similar studies have performed: Other studies have shown promise in using continuous glucose monitoring and remote patient monitoring for diabetes management, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults 18 years or older with Type 2 diabetes AND * A1c \> 8% Exclusion Criteria: * Pregnancy (participant-reported) * Previous real time CGM use for more than 6 weeks in the last 3 months * Use of steroids * Active cancer treatment * Terminal illness * Dementia, mental impairment * Type 1 diabetes * End stage renal disease, on dialysis
Where this trial is running
Greenfield, Massachusetts
- Community Health Center of Franklin County — Greenfield, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Sushma Reddy, MD — Diabetes Solutions International
- Study coordinator: Sushma Reddy, MD
- Email: sushreddyendo@yahoo.com
- Phone: 8103859699
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.